Kolexia
Chagraoui Abdeslam
Pharmacien
Hôpital Charles Nicolle
Rouen, France
55 Activités
309 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Dyskinésies Hémolyse Insuffisance hépatique Maladie aigüe Syndrome de Prader-Willi Anémie Dégénérescence hépatolenticulaire Maladies neurodégénératives

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino4,5-bindole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT receptor activation.
European journal of pharmacology   20 janvier 2024
To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease.
The international journal of biochemistry & cell biology   19 janvier 2024
Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats.
International journal of molecular sciences   29 septembre 2023
Coronaridine congeners induce sedative and anxiolytic-like activity in naïve and stressed/anxious mice by allosteric mechanisms involving increased GABA receptor affinity for GABA.
European journal of pharmacology   16 juin 2023
Deleting Snord115 genes in mice remodels monoaminergic systems activity in the brain toward cortico-subcortical imbalances.
Human molecular genetics   17 janvier 2023
(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission.
European journal of pharmacology   19 décembre 2022
Editorial: New GPCR targets and modulators to treat CNS disorders.
Frontiers in molecular neuroscience   06 décembre 2022
In Vivo Study of Monoamine Oxidases Using Multisite Intracerebral Microdialysis.
Methods in molecular biology (Clifton, N.J.)   30 septembre 2022
Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.
Frontiers in cellular neuroscience   23 mai 2022
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.
Biomolecules   01 février 2022